cancer therapeutics Market Research Reports

Titlepublishedprice

HER-2 Positive Breast Cancer Market in the US 2015-2019

By Infiniti Research Limited
"......differentiated carcinoma. Breast cancer is the second most common form of cancer in women. HER-2 is a protein that affects the growth of malignant cells and is usually found on the surface of normal breast cells. Sometimes, a large number of HER-2 re......"
18-Mar-2015$3000

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

By Infiniti Research Limited
"......Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types......"
18-Mar-2015$3000

Global HER-2 Positive Breast Cancer Market 2015-2019

By Infiniti Research Limited
"......differentiated carcinoma. Breast cancer is the second most common form of cancer in women. HER-2 is a protein that affects the growth of malignant cells and is usually found on the surface of normal breast cells. Sometimes, a large number of HER-2 re......"
4-Mar-2015$3000

Oncology Deals and Alliances of 2014

By Current Partnering
"......s, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provid......"
1-Mar-2015$1495

Breast Cancer Partnering 2010-2015

By Current Partnering
"......reast cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Breast Cancer Partnering 2010-2015 provides understanding and access to the breast cancer partnering deals and agreements entered in......"
1-Mar-2015$1795

Transitional Cell Cancer (Urothelial Cell Cancer) – Pipeline Review, H1 2015

By Global Markets Direct
"......onal Cell Cancer (Urothelial Cell Cancer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featur......"
24-Feb-2015$2000

T-Cell Leukemia – Pipeline Review, H1 2015

By Global Markets Direct
"......peutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for T-......"
24-Feb-2015$2000

Peripheral T-Cell Lymphomas (PTCL) – Pipeline Review, H1 2015

By Global Markets Direct
"......mplete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews k......"
24-Feb-2015$2000

Acute Lymphoblastic Lymphoma – Pipeline Review, H1 2015

By Global Markets Direct
"......tive analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved......"
10-Feb-2015$2000

Anal Cancer – Pipeline Review, H1 2015

By Global Markets Direct
"......sment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anal Cancer and......"
10-Feb-2015$2000
Live Chat
Live Chat by Comm100